Published in Synapse on September 01, 2008
Roux-en-Y gastric bypass surgery changes food reward in rats. Int J Obes (Lond) (2010) 1.41
An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol Behav (2009) 1.35
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol (2010) 1.33
"Liking" and "wanting" of sweet and oily food stimuli as affected by high-fat diet-induced obesity, weight loss, leptin, and genetic predisposition. Am J Physiol Regul Integr Comp Physiol (2011) 1.13
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts. Postgrad Med (2014) 1.04
Food restriction increases glutamate receptor-mediated burst firing of dopamine neurons. J Neurosci (2013) 0.92
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption. Alcohol Clin Exp Res (2010) 0.86
Impulsive-choice patterns for food in genetically lean and obese Zucker rats. Behav Brain Res (2012) 0.84
Food reward in the obese and after weight loss induced by calorie restriction and bariatric surgery. Ann N Y Acad Sci (2012) 0.83
Rimonabant's reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats. Psychopharmacology (Berl) (2014) 0.80
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor-Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators. Front Behav Neurosci (2016) 0.79
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets. Behav Pharmacol (2014) 0.78
Roux-en-Y Gastric Bypass Alters Brain Activity in Regions that Underlie Reward and Taste Perception. PLoS One (2015) 0.78
Odor-Induced Neuronal Rhythms in the Olfactory Bulb Are Profoundly Modified in ob/ob Obese Mice. Front Physiol (2017) 0.75
Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36
Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science (1996) 4.59
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest (2005) 4.55
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest (2003) 3.62
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am J Physiol Regul Integr Comp Physiol (2002) 3.33
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci (2002) 2.52
Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J Comp Neurol (1992) 2.32
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) (1997) 2.31
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol (2003) 2.12
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci U S A (1993) 2.10
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol (2001) 2.07
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) (2003) 1.61
Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron (2005) 1.58
Leptin gene expression in the brain and pituitary gland. Endocrinology (1999) 1.58
Neural systems recruited by drug- and food-related cues: studies of gene activation in corticolimbic regions. Physiol Behav (2005) 1.45
Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse (1999) 1.44
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes Obes Metab (2005) 1.37
Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav (2002) 1.37
CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology (2005) 1.33
Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res (2005) 1.31
The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension (1989) 1.21
Down-regulation of cannabinoid-1 (CB-1) receptors in specific extrahypothalamic regions of rats with dietary obesity: a role for endogenous cannabinoids in driving appetite for palatable food? Brain Res (2002) 1.16
Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Circulation (2006) 1.15
(-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. J Biol Chem (1996) 1.15
Cannabinoid (CB)1 receptor antagonist, AM 251, causes a sustained reduction of daily food intake in the rat. Physiol Behav (2004) 1.12
Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl) (2004) 1.11
Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci (2003) 1.04
Development of insulin resistance and hyperphagia in Zucker fatty rats. Am J Physiol Regul Integr Comp Physiol (2005) 1.02
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience (2003) 0.99
ESBRA-Nordmann 1996 Award Lecture: ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol (1997) 0.96
Suppressing effect of the cannabinoid CB1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur J Pharmacol (2004) 0.90
Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats. Behav Pharmacol (2005) 0.90
Leptin receptors are developmentally regulated in rat pituitary and hypothalamus. Mol Cell Endocrinol (2003) 0.87
Use of the beta-imager for rapid ex vivo autoradiography exemplified with central nervous system penetrating neurokinin 3 antagonists. J Pharmacol Exp Ther (2001) 0.83
Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligands. J Neurosci Methods (2006) 0.80
Dopamine in the VMN of the hypothalamus is important for diurnal distribution of eating in obese male Zucker rats. Nutrition (2000) 0.78
The lateral hypothalamus is involved in the pathway mediating the hypotensive response to cingulate cortex-cholinergic stimulation. Cell Mol Neurobiol (2001) 0.78
Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 10.34
Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend (2005) 6.91
Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci (2006) 5.69
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci (2011) 4.88
Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend (2006) 4.24
Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA (2009) 4.10
Effects of cell phone radiofrequency signal exposure on brain glucose metabolism. JAMA (2011) 4.03
The addicted human brain: insights from imaging studies. J Clin Invest (2003) 3.91
Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci (2008) 3.48
Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci (2010) 3.48
Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry (2007) 3.33
Functional connectivity density mapping. Proc Natl Acad Sci U S A (2010) 3.12
Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol (2007) 3.11
Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA (2009) 3.04
The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci (2009) 3.01
Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage (2008) 2.86
Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci U S A (2011) 2.62
Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med (2006) 2.57
Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol (2011) 2.51
Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem (2002) 2.50
Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48
The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology (2004) 2.46
Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis (2004) 2.45
Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence. Am J Psychiatry (2004) 2.42
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci (2005) 2.41
Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci (2007) 2.38
Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2007) 2.37
Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci U S A (2009) 2.27
Exposure to appetitive food stimuli markedly activates the human brain. Neuroimage (2004) 2.13
"Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse (2002) 2.13
Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry (2007) 2.09
Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci (2003) 2.08
Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia (2004) 2.07
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry (2007) 2.03
Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays (2010) 1.97
High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry (2006) 1.97
Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) (2008) 1.92
Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry (2009) 1.91
Functional connectivity hubs in the human brain. Neuroimage (2011) 1.87
Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage (2009) 1.87
Physician education in addiction medicine. JAMA (2013) 1.87
Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord (2003) 1.80
Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry (2004) 1.80
Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci U S A (2009) 1.79
Association between functional connectivity hubs and brain networks. Cereb Cortex (2011) 1.78
Abnormal functional connectivity in children with attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.76
Charting a course for health services research at the National Institute on Drug Abuse. J Subst Abuse Treat (2005) 1.74
Neuroscience networks: data-sharing in an information age. PLoS Biol (2003) 1.74
Gastric distention activates satiety circuitry in the human brain. Neuroimage (2007) 1.68
The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets (2002) 1.66
Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage (2007) 1.66
The neuropsychology of cocaine addiction: recent cocaine use masks impairment. Neuropsychopharmacology (2008) 1.63
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain (2004) 1.61
The addictive dimensionality of obesity. Biol Psychiatry (2013) 1.59
Medicine. Spatial turn in health research. Science (2013) 1.57
Monoamine oxidase and cigarette smoking. Neurotoxicology (2003) 1.57
Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse (2002) 1.56
Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One (2008) 1.54
Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med (2005) 1.53
Enhanced striatal dopamine release during food stimulation in binge eating disorder. Obesity (Silver Spring) (2011) 1.52
Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS One (2009) 1.51
Brain monoamine oxidase A activity predicts trait aggression. J Neurosci (2008) 1.51
Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug Alcohol Depend (2006) 1.48
Brain dopamine transporter levels in treatment and drug naïve adults with ADHD. Neuroimage (2006) 1.47
Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A (2006) 1.46
Imaging the addicted human brain. Sci Pract Perspect (2007) 1.45
Thalamo-cortical dysfunction in cocaine abusers: implications in attention and perception. Psychiatry Res (2007) 1.44
Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.43
Energetic cost of brain functional connectivity. Proc Natl Acad Sci U S A (2013) 1.42
Translating glutamate: from pathophysiology to treatment. Sci Transl Med (2011) 1.42
Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci (2008) 1.41
Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res (2010) 1.41
Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications. Synapse (2002) 1.38
D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse (2008) 1.38
Adverse health effects of marijuana use. N Engl J Med (2014) 1.37
Neurobiologic Advances from the Brain Disease Model of Addiction. N Engl J Med (2016) 1.36
Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage (2008) 1.35
Disrupted functional connectivity with dopaminergic midbrain in cocaine abusers. PLoS One (2010) 1.34
Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: a preliminary study. Psychiatry Res (2002) 1.33
What are the long-term effects of methylphenidate treatment? Biol Psychiatry (2003) 1.33
Motivated attention to cocaine and emotional cues in abstinent and current cocaine users--an ERP study. Eur J Neurosci (2011) 1.32
Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res (2005) 1.31